Zydus Cadila and Taiwan-based specialty pharmaceutical firm TLC on Wednesday said they have signed a pact to market Liposomal Amphotericin B, a critical drug to treat mucormycosis (black fungus), in India.
from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/34jw5KO
No comments:
Post a Comment